These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7517183)

  • 1. Serum screening for Down's syndrome.
    Bibby J; McCormack MJ
    Br J Obstet Gynaecol; 1994 Jun; 101(6):557-8. PubMed ID: 7517183
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of gravidity on Down's syndrome screening with free beta hCG.
    Spencer K
    Prenat Diagn; 1995 Jan; 15(1):87-9. PubMed ID: 7537879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
    Wald NJ; Densem JW
    Prenat Diagn; 1994 Aug; 14(8):717-9. PubMed ID: 7527538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of free beta-hCG in Down's syndrome screening.
    Wald N; Hackshaw A; Haddow JE; Palomaki GE; Knight GJ
    Ann Clin Biochem; 1993 Sep; 30 ( Pt 5)():512-8. PubMed ID: 7504428
    [No Abstract]   [Full Text] [Related]  

  • 5. Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.
    Spencer K; Coombes EJ; Mallard AS; Ward AM
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():506-18. PubMed ID: 1280026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum screening for Down syndrome before 15 weeks.
    Cuckle H; Lilford R; Jones R
    Am J Obstet Gynecol; 1994 Mar; 170(3):959. PubMed ID: 7511335
    [No Abstract]   [Full Text] [Related]  

  • 7. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta hCG.
    Spencer K; Salonen R; Muller F
    Prenat Diagn; 1994 Jul; 14(7):537-42. PubMed ID: 7526363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum screening for chromosome defects: human chorionic gonadotropin versus its free-beta subunit.
    Milunsky A; Nebiolo LM; Bellet D
    Fetal Diagn Ther; 1993; 8(4):221-4. PubMed ID: 7505085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum free alpha- and free beta-human chorionic gonadotrophin in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
    Wald NJ; Densem JW; Cheng R; Collishaw S
    Prenat Diagn; 1994 Sep; 14(9):835-7. PubMed ID: 7531328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia.
    Cheffins T; Chan A; Haan EA; Ranieri E; Ryall RG; Keane RJ; Byron-Scott R; Scott H; Gjerde EM; Nguyen AM; Ford JH; Sykes S
    BJOG; 2000 Dec; 107(12):1453-9. PubMed ID: 11192100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin.
    Macri JN; Kasturi RV; Krantz DA; Cook EJ; Moore ND; Young JA; Romero K; Larsen JW
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1248-53. PubMed ID: 1699417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum screening for Down's syndrome in the first trimester of pregnancy.
    Biagiotti R; Cariati E; Brizzi L; D'Agata A
    Br J Obstet Gynaecol; 1995 Aug; 102(8):660-2. PubMed ID: 7544611
    [No Abstract]   [Full Text] [Related]  

  • 16. Down's syndrome screening: value of using free beta-hCG.
    Densem J; Wald NJ
    Prenat Diagn; 1995 Jan; 15(1):94-5. PubMed ID: 7537881
    [No Abstract]   [Full Text] [Related]  

  • 17. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood screening for Down's syndrome in women under 35 years of age with an age-independent index].
    Benz R; Müller U; Krahner-Pilat M; Wagner-Geuder S; Terinde R
    Z Geburtshilfe Perinatol; 1993; 197(5):205-8. PubMed ID: 7505992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trisomy-21 screening using AFPplus in the eastern part of Switzerland].
    Zimmermann R; Schmid W; Binkert F; Achermann J; Huch R; Huch A
    Schweiz Med Wochenschr; 1995 Jul; 125(26):1286-93. PubMed ID: 7541552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ; Watt HC
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.